Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wuxi Hebang Biotechnology is a specialized life sciences company based in Wuxi, China, focusing on the research, development, and manufacture of peptide-related products. The company provides a comprehensive suite of services including custom peptide synthesis, the production of protected amino acids, and the development of peptide fragments for pharmaceutical applications. As a Contract Research and Manufacturing Organization (CRO/CDMO), Wuxi Hebang supports global drug discovery efforts by providing high-quality chemical building blocks and scale-up capabilities. Their expertise spans from laboratory-scale R&D to commercial-grade production of complex peptides and organic intermediates. The company serves a diverse clientele ranging from academic institutions to large pharmaceutical corporations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wuxi Hebang Biotechnology.